Arbutus Biopharma (ABUS) Q1 2026 Earnings Report

1,286 Followers

ABUS Q1 2026 EPS Results

Actual EPS$0.87

Consensus EPS-$0.03

Beat/MissBeat by +$0.90

One Year Ago EPS-$0.13

Actual Revenue$179.13M

Expected Revenue$750.00K

Beat/MissBeat by +$178.38M

YoY Revenue Growth+10054.54%

QuarterQ1 2026

Date05/13/2026

TimeBefore Open

Conference CallWednesday, May 13, 2026

ABUS Upcoming Earnings

Arbutus Biopharma's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	-0.02 / -	-0.04	―
Aug 12, 2026	2026 (Q2)	-0.02 / -0.03	0.01	-400.00% (-0.04)
May 13, 2026	2026 (Q1)	-0.03 / 0.87	-0.13	769.23% (+1.00)
Mar 23, 2026	2025 (Q4)	-0.04 / -0.01	-0.07	85.71% (+0.06)
Nov 13, 2025	2025 (Q3)	-0.03 / -0.04	-0.1	60.00% (+0.06)
Aug 06, 2025	2025 (Q2)	-0.05 / 0.01	-0.11	109.09% (+0.12)
May 14, 2025	2025 (Q1)	-0.10 / -0.13	-0.1	-30.00% (-0.03)
Mar 27, 2025	2024 (Q4)	-0.08 / -0.07	-0.12	41.67% (+0.05)
Nov 06, 2024	2024 (Q3)	-0.09 / -0.10	-0.12	16.67% (+0.02)
Aug 01, 2024	2024 (Q2)	-0.10 / -0.11	-0.1	-10.00% (>-0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed